Skip to search formSkip to main contentSkip to account menu

PASD1 gene

Known as: PAS Domain Containing 1 Gene, cancer/testis antigen 63, PASD1 
This gene may be involved in transcriptional regulation.
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Genes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PAS Domain Containing Repressor 1 (PASD1) Promotes Glioma Cell Proliferation Through Inhibiting Apoptosis In Vitro
Background PAS domain containing repressor 1 (PASD1), the cancer-testis antigen (CTA), has been reported to be aberrantly… 
2018
2018
Экспрессия раково-тестикулярных генов PRAME, NY-ESO1, GAGE1, MAGE a3, MAGE a6, MAGE a12, SSX1, sllp1, PASD1…
2018
2018
EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
Objective:to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE… 
2018
2018
Validation of PASD1 as an immunotherapeutic target in colorectal cancer (CRC)
2016
2016
Exploring complex diseases through translational research.
Translational research as a new strategy promotes the integration of life science and clinical research, by which important… 
2015
2015
Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
Ovarian cancer is very treatable in the early stages of disease; however, it is usually detected in the later stages, at which… 
2010
2010
Development of a novel DNA vaccine encorporating a PASD1 analogue peptide which can enhance anti-leukaemia T cell responses in vitro and in vivo
2009
2009
Cytolytic T‐cell response to the PASD1 cancer testis antigen in patients with diffuse large B‐cell lymphoma
The identification of immunogenic cancer testis antigens (CTAs) as immunotherapeutic targets represents one approach to improve… 
2006
2006
PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy
Despite advances in defining clinically relevant subtypes of diffuse large B-cell lymphoma (DLBCL), identifying high-risk… 
2005
2005
Protein Expression Profiles Confirm PASD1 as a Cancer Testis Antigen and a Potential Candidate for Lymphoma Immunotherapy.
Advances in gene expression profiling and immunolabeling techniques have provided evidence of clinically relevant subtypes within… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)